Photosensitivity in the pediatric patient

Current Opinion in Pediatrics

Volumn 9, Issue 4, 1997, Pages 377-387

  Garzon, Maria C ^a   DeLeo, Vincent A ^a  

^a Department of Dermatology ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; ANTIHISTAMINIC AGENT; ANTIINFECTIVE AGENT; BETA CAROTENE; CARBAMAZEPINE; CORTICOSTEROID; FRAGRANCE; GRISEOFULVIN; LUMITENE; MUSK AMBRETTE; NAPROXEN; NEUROLEPTIC AGENT; NICOTINAMIDE; NONSTEROID ANTIINFLAMMATORY AGENT; OXYBENZONE; PIROXICAM; PROMETHAZINE; PSORALEN DERIVATIVE; RETINOID; SUNSCREEN; TAR; TETRACYCLINE DERIVATIVE; THALIDOMIDE; TOPICAL AGENT; TRYPTOPHAN; UNCLASSIFIED DRUG;

BLOOM SYNDROME; CHILD; CLINICAL FEATURE; COCKAYNE SYNDROME; DERMATOMYOSITIS; DIARRHEA; DIFFERENTIAL DIAGNOSIS; DISEASE PREDISPOSITION; EARLY DIAGNOSIS; FENNEL; HARTNUP DISEASE; HUMAN; IDIOPATHIC DISEASE; LUPUS ERYTHEMATOSUS; ORAL DRUG ADMINISTRATION; PEDIATRICS; PHOTOSENSITIVITY DISORDER; PLANT DERMATITIS; PORPHYRIA; PRIORITY JOURNAL; RADIATION INJURY; REVIEW; RISK FACTOR; ROTHMUND THOMSON SYNDROME; SKELETON MALFORMATION; SKIN DISCOLORATION; SUN EXPOSURE; SUNLIGHT; TOPICAL DRUG ADMINISTRATION; ULTRAVIOLET RADIATION; XERODERMA PIGMENTOSUM;

EID: 0030765125     PISSN: 10408703     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008480-199708000-00013     Document Type: Review

References (101)

1. Cohen PR, DeLeo VA: The Porphyrias in Genetic Disorders of the Skin. Edited by Alper JC. Chicago: Mosby Yearbook; 1991.
2. Waldenstrom J: The porphyrias as inborn errors of metabolism. Am J Med 1957, 22:758-773.
3. Waldenstrom J: Geography and genetics of the porphyrias. Acta Derm Venereol Suppl (Stockh) 1982, 100:43-46.
4. Poh-Fitzpatrick MB: The porphyrias. Dermatol Clin 1987, 5:55-61.
5. Piomelli S, Poh-Fitzpatrick MB, Seaman C, Skolnick LM, Berdon WE: Complete suppression of the symptoms of congenital erythropoietic porphyria by long-term treatment with high-level transfusions. N Engl J Med 1986, 314:1029-1031.
6. Xu W, Astrin KH, Desnick RJ: Molecular basis of congenital erythropoietic porphyria: mutations in the human uroporphyrinogen III synthase gene. Hum Mutat 1996, 7:187-92.
7. Seip M, Thune PO, Eriksen L: Treatment of photosensitivity in congenital erythropoietic porphyria with beta carotene. Acta Derm Venereol 1974, 54:239-240.
8. Pimstone NR, Gandhi SN, Mukerji SK: Therapeutic efficacy of oral charcoal in congenital erythropoietic porphyria. N Engl J Med 1987, 316:390-393.
9. DeLeo VA, Cohen PR: Porphyrias. In Topics in Clinical Dermatology: Photosensitivity. Edited by DeLeo VA. New York: Igaku-Shoin; 1992:100-115.
10. Haining RG, Labbe RF, Cowger ML: Hypertransfusion in congenital erythropoietic porphyria. Clin Res 1967, 15:131-136.
11. Wang X, Poh-Fitzpatrick M, Chen T, Malavade K, Carriero O, Piomelli S: Systemic screening for RNA with skipped exons-splicing mutations in the ferrochelastase gene. Biochem Biophys Acta 1995, 1271:356-362.
12. Todd DJ, Hughes AE, Ennis RT, Ward AJ, Burrows D, Nevin NC: Identification of a single base pair deletion in the ferrochelatase gene in erythropoietic protoporphyria. Hum Mol Genet 1993, 2:1495-1496.
13. Schneider-Yin X, Schafer BW, Tonz O, Minder EI: Human ferrochelatase: a novel mutation in patients with erythropoietic protoporphyria and an isoform caused by alternative splicing. Hum Genet 1995, 95:391-396.
14. DeLeo VA, Poh-Fitzpatrick MB, Mathews-Roth M, Harberf LC: Erythopoietic protoporphria: 10 years experience. Am J Med 1976, 60:8-22.
15. Mion FB, Faure JL, Berger F, McGregor B, Perrot H, Paliard P: Liver tranplantation for erythropoietic Protoporphyria. Report of a new case with subsequent medium-term follow-up. J Hepatol 1992, 16:203-207.
16. Frank, Doss MO: Liver cirrhosis in protoorphyria: bile acid therapy and liver transplantation. Z Gastroenterol 1995, 33:399-403.
17. Mathews-Roth MM: Beta-carotene therapy for erythropoietic protoporphyria and other photosensitivity diseases. Biochimie 1986, 68:875-884.
18. Cleaver JE: Defective repair replication of DNA in xeroderma pigmentosum. Nature 1968, 218:652-656.
19. Scriver CR, Beaudet AL, Sly WS, Valle D, Stranbury JB, Wyngaarden JB, Fredrickson DS: The Metabolic and Molecular Basis of Inherited Disease, edn 7. New York: McGraw Hill; 1995:4393-4419.
20. Kraemer KH, Lee MM, Scotto J: Xeroderma pigmentosum: cutaneous ocular, and neurologic abnormalities in 830 published cases. Arch Dermatol 1987, 123:241-250.
21. Goyal JL, Roa VA, Srinivasan R, et al.: Oculocutaneous manifestations in xeroderma pigmentosum. Br J Ophthalmol 1994, 78:295-297.
22. Lambert WC, Kuo HR, Lambert MW: Xeroderma pigmentosum. Dermatol Clin 1995, 13:169-209.
23. Tanaka K, Wood RD: Xeroderma pigmentosum and nucleotide excision repair of DNA. TIBS 1994, 19:83-86.
24. Sato M, Nishigori C, Zghal, Takashi Y, Takebe H: Ultraviolet specific mutations in p53 gene in skin tumors of xeroderma pigmentosum patients. Cancer Res 1993, 53:2944-2946.
25. Dumaz N, Stary A, Soussi T, Daya-Grosjean L, Sarasin A: Can we predict solar ultraviolet radiation as the causal event in human tumors by analysing the mutation spectra of the p53 gene? Mutat Res 1994, 94:375-386.
26. Tanaka K, Miura N, Satokata I, Miyamoto I, Yoshida MC, Satoh Y, Kondo S, Yasui A, Okayama H, Okada Y: Analaysis of a human DNA excision repair gene involved in group A xeroderma pigmentosum and containing a zinc finger domain. Nature 1990, 348:73-76.
27. Weeda G, Bootsma D, Van Ham RCA, et al.: A presumed DNA helicase encoded by ERCC-3 is involved in the human brepair disorder xeroderma pigmentosum and Cockayne's syndrome. Cell 1990, 62:777-791.
28. Schaeffer L, Roy R, Humbert S, Moncollin V, Vermeulen W, Hoeijmakers JH, Chambon P, Egly JM: DNA repair helicase: a component of BTF2 (TFIH) basic transcription factor. Science 1993, 260:58-63.
29. Legerski R, Peterson C: Expression cloning of a human DNA repair gene involved in xeroderma pigmentosum group C. Nature 1992, 359:70-73.
30. Van der Spek P, Eker A, Rademakers S, Visser C, Sugasawa K, Masutani C, Hanaoka F, Bootsma D, Hoeijmakers JH: XPC and human homologs of RAD23: intracellular localization and relationship to other nucleotide excision repair complexes. Nucleic Acids Res 1996, 24:2551-2559.
31. Flejter W, McDaniel LD, Johns D, Friedberg EC, Schultz RA: Correction of xeroderma pigmentosum complementation group D mutant cell phenotypes by chromosome and gene transfer: Involvement of the human ERCC2 DNA repair gene. Proc Natl Acad Sci U S A 1992, 89:261-265.
32. Kazantsev A, Mu D, Nichols AF, Zhao X, Linn S, Sancar A: Functional complementation of xeroderma pigmentosum complementation group E by replication protein A in an in vitro system. Proc Natl Acad Sci U S A 1996, 93:5014-5018.
33. Sijbers AM, de Laat WL, Ariza RR, Biggerstaff M, Wei Y, Moggs JG, Carter KC, Shell BK, Evans E, deJong MC, Rademakers S, de Rooij J, Jaspers NGJ, Hoeijmakers JHJ, Wood RD: Xeroderma pigmentosum group F caused by a defect in a stucture specific DNA repair endonuclease. Cell 1996, 86:811-822.
34. Scherly D, Nouspikel T, Corlet J, Ucla C, Bairoch A, Clarkson SG: Complementation of the DNA repair defect in xeroderma pigmentosum group G cells by human cDNA related to yeast RAD2. Nature 1993, 363:182-185.
35. Kore-eda S, Tanaka T, Moriwaki S, Nishigori C, Imamura S: A case of xeroderma pigmentosum group A diagnosed with polymerase chain reaction technique. Arch Dermatol 1992, 128:971-974.
36. Matsumoto N, Saito N, Harada N, Lanaka K, Niikawa N: DNA-bases prenatal carrier detection for group A xeroderma pigmentosum in a chorionic villus sample. Prenat Diagn 1995, 15:675-677.
37. Kraemer KH, DiGiovanna JJ, Moshell AN, Tarone RE, Peck GL: Prevention of skin cancer in xeroderma pigmentosum with the use of oral isotretinoin. N Engl J Med 1988, 318:1633-1637.
38. Berth-Jones J, Lehmann AR, Graham-Brown RA, Cole J, Arlett CF: Xeroderma pigmentosum variant: 5 years of tumor supression with etretinate. J R Soc Med 1993, 86:355-356.
39. Kraemer KH, DiGiovanna JJ, Peck GL: Chemoprevention of skin cancer in xeroderma pigmentosum. J Dermatol 1992, 19:715-717.
40. Halkier-Sorenson L, Laurberg G, Andersen J: Bone changes in children on long-term treatment with etretinate. J Am Acad Dermatol 1987, 16:999-1006.
41. Prendiville J, 41. Bingham MB, Burrows D: Premature epiphyseal closure-a complication of etretinate therapy in children. J Am Acad Dermatol 1986, 15:1259-1262.
42. Yarosh DB: Liposome-encapsulated DNA repair enzyme: potential treatment for xeroderma pigmentosum and related disorders. Dermatol Focus 1996, 15:1.
43. Cockayne EA: Dwarfism with retinal atrophy and deafness. Arch Dis Child 1936, 11:1-8.
44. Nance MA, Berry SA: Cockayne syndrome: review of 140 cases. Am J Med Genet 1992, 42:68-84.
45. Andrews AD, Barrett SF, Yoder FW, Robbins JH: Cockayne's syndrome fibroblasts have increased sensitivity to ultraviolet light but normal rates of unscheduled DNA synthesis. J Invest Dermatol 1978, 70:237-239.
46. Jaeken J, Klocker H, Schwaiger H, Bellmann R, Hirsch-Kauffmann M, Schweiger M: Clinical and biochemical studies in three patients with severe early infantile Cockayne syndrome. Hum Genet 1989, 83:339-346.
47. Venema J, Mullenders LH, Natarajan AT, van Zeeland AA, Mayne LV: The genetic defect in Cockayne syndrome is associated with a defect in repair of UV induced damage in transcriptionally active DNA. Proc Natl Acad Sci U S A 1990, 87:4707-4711.
48. Parris CN Kraemer KH: Ultraviolet-induced mutations in Cockayne syndrome cells are primarily caused by cyclobutane dimer photoproducts while repair of other photoproducts is normal. Proc Natl Acad Sci U S A 1993, :7260-7264.
49. Toelstra C, Van Gool A, DeWit J, Vermeulen W, Bootsma D, Hoeijmakers JH: ERCC6, a member of a subfamily of putative helicases, is involved in Cockayne syndrome and preferential repair of active genes. Cell 1992, 71:939-953.
50. German J: Bloom's syndrome. Dermatol Clin 1995, 13:7-18.
51. Van Kerckhove CW, Ceuppens JL, Vanderschueren-Lodeweyckx M, et al.: Bloom's syndrome: clinical features and immunologic abnormalities of four patients. Am J Dis Child 1988, 142:1089-1093.
52. Warren ST, Schultze RA, Chang CC, Wade MH, Trosko JE: Elevated spontaneous mutation rate in Bloom syndrome fibroblasts. Proc Natl Acad Sci U S A 1981, 78:3133-3137.
53. Langlois RG, Bigbee WL, Jensen RH, German J: Evidence for increased in vivo mutation and somatic recombination in Bloom's syndrome. Proc Natl Acad Sci U S A 1989, 86:670-674.
54. McDaniel LD, Schultz R: Elevated sister chromatid exchange phenotype of Bloom syndrome cells is complemented by human chromosome 15. Proc Natl Acad Sci U S A 1992, 89:7968-7972.
55. Ellis NA, Groden J Ye TZ, Staughen J, Lennon DJ, Ciocci S, Proytcheva M, German J: The Bloom syndrome gene product is homologous to the RecQ helicases. Cell 1995, 83:655-666.
56. Taylor WB: Rothmund's syndrome-Thompson's syndrome. Arch Dermatol 1957, 75:236-244.
57. Thomson MS: A hitherto undescribed familial disease. Br J Dermatol 1923, 35:455-462.
58. Moss C: Rothmund Thomson syndrome: a report of two patients and a review of the literature. Br J Dermatol 1990, 122:821-829.
59. Vennos EM, Collins M, James WD: Rothmund-Thomson syndrome: review of the world literature. J Am Acad Dermatol 1992, 27:750-762.
60. Vennos EM James WD: Rothmund Thomson syndrome. Dermatol Clin 1995, 13:143-150.
61. Smith PV, Paterson MC: Enhanced radiosensitivity and defective DNA repair on cultured fibroblasts derived from Rothmund-Thomson syndrome patients. Mutat Res 1982, :94-213-228.
62. Cleaver JE: DNA damage and repair in light-sensitive human skin disease. J Invest Dermatol 1970, 54:181-195.
63. Fujiwara Y: Rothmund-Thomson syndrome. Pediatr Int 1989, 21:126-128.
64. Shinya A, Nishigon C, Moriwaki S, et al.: A case of Rothmund Thomson syndrome with reduced DNA repair capacity. Arch Dermatol 1993, 129:332-336.
65. Ying KL, Oizumi J, Curry CJ: Rothmund Thomson syndrome associated with trisomy 8 mosalcism. J Med Genet 1990, 27:258-260.
66. Der Kaloustian VM, McGill JJ, Vekemans, Kopelman HR: Clonal lines of aneuploid cells in Rothmund-Thomson syndrome. Am J Med Genet 1990, 37:336-339.
67. Orstavik KH, McFadden N, Hagelsteen J, Ormerod E, Van Der Hagen CB: instability of lymphocyte chromosomes in a girl with Rothmund Thomson syndrome. J Med Genet 1994, :570-572.
68. Irons M, Levy HL: Metabolic syndromes with dermatologic manifestations. Clin Rev Allergy 1986, 4:101-124.
69. Oakley A Wallace J: Hartnup disease presenting in an adult. Clin Exp Dermatol 1994, 19:407-408.
70. Jonas, AJ, Butler IJ: Circumvention of the defective neutral amino acid transport in Hartnup disease using tryptophan ethyl ester. J Clin Invest 1989, 84:200-204.
71. Barthelemy H, Chouvet B, Cambazard F: Skin and mucosal manifestations in vitamin deficiency. J Am Acad Dermatol 1988, 15:1263-1274.
72. Cassidy JT, Petty RE: Textbook of Pediatric Rheumatology, edn 2. New York: Churchill Livingstone; 1990:261.
73. Lehman, TJ, McCurdy DK, Bernstein BH, King KK, Hanson V: Systemic lupus erythematosus in the first decade of life. Pediatrics 1989, 83:235-239.
74. Woo TR, Rasmussen J, Callen JP: Recurrent photosensitive dermatitis preceding juvenile dermatomyositis. Pediatr Dermatol 1985, 2:207-212.
75. Lee LA: Neonatal lupus erythematosus. J Invest Dermatol 1993, 100:9s-13s.
76. Ho SY, Esscher, E Anderson RH, Michaelsson M: Anatomy of congenital complete heart block and relation to maternal anti-Ro antibodies. Am J Cardiol 1986, 58:291-294.
77. Alexander E Buyon JP, Provost TT, Gyarbueru T: Anti-Ro/RR-A antibodies in the pathophysiology of congenital heart block in neonatal lupus syndrome, an experimental model. Arthritis Rheum 1992, 35:176-189.
78. Lee LA Bias WB, Arnett FC, Huff JC, Norris DA, Harmon C, Provost TT, Weston WL: Immunogenetics of the neonatal lupus syndrome. Ann Intern Med 1983, 99:592-596.
79. Paller AS: Juvenile dermatomyositis and overlap syndromes. Adv Dermatol 1995, 10:309-326.
80. Frain-Bell W, Scatchard M: The association of photosensitivity and atopy in the child. Br J Dermatol 1971, 85:105-110.
81. De Leo VA: Photosensitivity Diseases, edn 1. New York: Igaku Shoin; 1992:133-141.
82. Pigatto PD, Altomare G, Polenghi MM, Roveroni S, Menni S, Socchio F: Atopy and photosensitivity in children. Photodermatology 1986, 3:303-310.
83. Morrison WL, Stern RS: Polymorphous light eruption: a common reaction uncommonly recognized. Acta Derm Venerol 1982, 63:237-240.
84. Sundohara A, Nobuyuki M, Sakai M: Action spectrum for UV erythema and reproduction of the skin lesions Hydroa vacciniforme. Photodermatology 1983, 5:139-145.
85. Goldegier MH, Morlund JJ, Lucky AW: Hydroa vacciniforme diagnosis and therapy. Arch Dermatol 1983, 18:588-391.
86. Sonnex TS, Haek JLM: Hydroa vacciniforme: a review of ten case. Br J Dermatol 1988, 118:101-108.
87. Lane PR, Hogan DJ, Martel MJ, Reeder B, Irvine J: Actinic prurigo: clinical features and prognosis. J Am Acad Dermatol 1992, 26:683-92.
88. Lane PR, Murphy F, Hogan DJ, Hull PR, Burgdorf WHC: Histopathology of actinic prurigo. Am J Dermatopathol 15:326-331.
89. Farr PM, Diffey BL: Treatment of actinic prurigo with PUVA, mechanism of action. Br J Dermatol 1989, 120:411-418.
90. Lane PR, Moreland AA, Hogan DJ: Treatment of actinic prurigo with intermittent short course topical 0.05% clobetasol 17-propinoate: a preliminary report. Arch Dermatol 1990, 126:1211-1213.
91. Schwartz K, Spack M: Experimentelle untersuchungen zur frage der photoallergic der sulphoramide. Dermatologica 1957, 114:232-243.
92. Chignell CF, Kalyaraomen B, Mason RP, Sik RH: Spectroscopic studies of cutaneous photosensitizing agents. Photoder Photobiol 1980, 32:563-571.
93. Elmets CA: Drug-induced photoallergy. In Photosensitivity: Dermatology Clinics. Edited by DeLeo VA. New York: WB Saunders; 1986:231-241.
94. Thune P, Jansen C, Wennersten G, Rystedt I, Brodthagen H, McFadden N: The Scandinavian multicenter photopatch study 1980-1985: final report. Photodermatology 1988, 5:261-269.
95. Ophaswongse S, Maibach H: Topical nonsteroidal antiinflammatory drugs: allergic and photoallergic contact dermatitis and phototoxicity. Contact Dermatitis 1993, 29:57-64.
96. Pigatto PD, Mozzanica N, Bigardi AS, Legoria A, Cusano F, Tosti A, Guarrera M, Balato N, Sertoli A: Topical NSAID allergic contact dermatitis: Italian experience. Contact Dermatitis 1993, 29:39-41.
97. Trevisi P, Vincenzi C, Chieregato C, Guerra L, Tosti A: Sunscreen sensitization: a three-year study. Dermatology 1994, 189:55-77.
98. Collins P, Ferguson J: Photoallergic contact dermatitis to oxybenzone. Br J Dermatol 1994, 131:124-129.
99. Foley P, Nixon R, Marks R, Frowen K, Thompson S: The frequency of reactions to sunscreens: results of a longitudinal population-based study on the regular use of sunscreens in Australia. Br J Dermatol 1993, 128:512-518.
100. Goskowicz MA, Fallon Friedlander S, Eichenfield LF: Endemic "lime" disease: Phytophotodermatitis in San Diego. Pediatrics 1994, 93:828-830.
101. DeLeo VA: Photocontact dermatitis. In Current Opinion in Dermatology. Edited by Dahl MV. Philadelphia: Rapid Science Publishers; 1996:177-185.